Continue Reading
Full article on Unknown
Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
Market Intelligence Analysis
AI-Powered
Why This Matters
Cybin Inc. plans to transfer its U.S. stock exchange listing from NYSE American to Nasdaq Global Market, expecting its common shares to cease trading on NYSE American upon completion.
Market Impact
Market impact analysis based on neutral sentiment with 78% confidence.
Sentiment
Neutral
AI Confidence
78%
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
TORONTO, December 18, 2025--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) , a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market ("Nasdaq") from the NYSE American LLC ("NYSE American"). The Company expects that its common shares will cease trading on the NYSE American at market clo
Original article published by
Unknown
on December 18, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.